参考文献/References:
[1] Zhang L,Li H,Ji QH,et al.The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease[J].BMC Cancer,2012,21（12）：610-618.
[2] Büyüka?鬤ik O,Hasdemir AO,Yal?觭?覦n E,et al.The association between thyroid malignancy and chronic lymphocytic thyroiditis：should it alter the surgical approach?[J].Endokrynol Pol,2011,62（4）：303-308.
[3] Burgess JR,Tucker P.Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology[J].Thyroid,2006,16（1）：47-53.
[4] Ahn D,Heo SJ,Park JH,et al.Clinical relationship between Hashimoto,s thyroiditis and papillary thyroid cancer[J].Acta Oncologica,2011,50（8）：1228-1234.
[5] Gul K,Dirikoc A,Kiyak G,et a1.The association between thyroid carcinoma and Hashimoto s thyroiditis：the ultrasonographic and histopathologic characteristics of malignant nodules[J].Thyroid,2010,20（8）：873-878．
[6] Giagourta I,Evangelopoulou C,Papaioannou G,et al.Autoim-mune thyroiditis in benign and malignant thyroid nodules：16-year results[J].Head Neck,2013,36（4）：531-535.
[7] Nikiforov YE.Is ionizing radiation responsible for the increasing incidence of thyriod cancer ?[J].Cancer,2010,116（7）：1626-1628.
[8] Hall EJ,Brenner DJ.Cancer risks from diagnostic radiology[J].Br J Radiol,2008,81（965）：362-378.
[9] Hatch M,Furukawa K,Brenner A,et al.Prevalence of hyperthy-roidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident：dose-response results from the Ukrainian-American Cohort Study[J].Radiat Res,2010,174（6）：763-772.
[10] Knobel M,Medeiros-Neto G.Relevance of iodine intake as a reputed predisposing factor forthyroid cacer[J].Arq Bras Endocrinol Metabol,2007,51（5）：701-712.
[11] Dong W,Zhang H,Zhang P,et al.The changing inci-dence of thyroid carcinoma in Shen yang,China before and after universal salt iodization[J].Med Sci Monit,2013, 19： 49-53.
[12] Liu XH,Chen GG,Vlantis AC,et al.Iodine mediated mecha-nisms and thyroid carcinoma[J].Crit Rev Clin Lab Sci,2009,46（5-6）：302-318.
[13] Latrofa F,Fiore E,Rago T,et al.Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin[J].Clin Endocrinol Metab,2013,98（11）：E1768-E1774.
[14] Guan HX,Ji MJ,Bao R,et al.Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer[J].J Clin Endocrinol Metab,2009,94（5）：1612-1617.
[15] Yu X,Fan C,Shan Z,et al.A five-year follow-up study of goiter and thyroid nodules in three regions with different iodine intakes in China[J].J Endocrinol Invest,2008,31（3）：243-250．
[16] Kim KW,Park YJ,Kim EH,et al.Elevated risk of papillarythy-roid cancer in Korean patients with Hashimoto's thyroiditis[J].Head Neck,2011,33（5）：691-695.
[17] Haymart MR,Glinberg SL,Liu J,et al.Higher serum TSH in thyr oid cancer patients occurs independent of age and corre-lates with extrathyroidal extension[J].Clin Endocr inol （Oxf）, 2009,71（3）：434-439.
[18] 李清怀,张晓娟,李筱雨,等.促甲状腺激素受体在分化型甲状腺癌组织中的表达及意义[J].中华肿瘤杂志,2013,35（10）：751-753.
[19] Takahashi M,Saenko VA,Rogounovitch TI,et al.The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl[J]. Hum Mol Genet,2010,19（12）：2516-
2523.
[20] Cunha LL,FerreiraRC,Marcello MA,et al.Clinical and patho-logical implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer[J].Thyroid Res,2011,2011：387062.
[21] Givens DJ,Buchmann LO,Agarwal AM,et al.BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma[J].Laryngoscope,2014,[Epub ahead of print].
[22] Kim KH,Suh,KS,Kang DW,et al.Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis[J]. Pathol Intern,2005,55（9）：540-545.
[23] Kim EY,Kim WG,Kim WB,et al.Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma[J]. Clin Endocrinol （Oxf）,2009,71（4）：581-586.
[24] Cordioli ML,Cury AN,Nascimento AO,et al.Study of the histo-logical profile of papillary thyroid carcinomas associated with Hashimoto,sthyroiditis[J].Arg Bras Endocrinol Metab,2013,57（6）：445-449.
[25] Jeong JS,Kim HK,Lee CR,et al.Coexistence of chronic lym-phocytic thyroiditis with papillary thyroid carcinoma：clinical manifestation and prognostic outcome[J].Korean Med Sci,2012,27（8）： 883-889.
[26] Del Rio P,Cataldo S,Sommaruga L,et al.The association between papillary carcinoma and chronic lymphocytic thyroiditis：does it modify the prognosis of cancer?[J].Minerva Endocrinol,2008,33（1）：1-5.
[27] Kim EY,Kim WG,Kim WB,et al.Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma[J].Clin Endocrinol（Oxf）,2009,71（4）：581-586.
[28] Ramaswamy M,Cleland SY,Cruz AC,et al.Many checkpoints on the road to cell death：regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses[J].Results Probl Cell Differ,2009,49：17-47.
相似文献/References:
[1]李兴佳 曹萌 刘超.自噬与甲状腺癌的关系[J].国际内分泌代谢杂志,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
Li Xingjia,Cao Meng,Liu Chao..Relationship between autophagy and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2015,(03):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
[2]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(03):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[3]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌：临床新启示[J].国际内分泌代谢杂志,2014,(02):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(03):87.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
[4]孙洪平,陈国芳,曹雯,等.糖尿病与甲状腺癌关系的研究进展[J].国际内分泌代谢杂志,2014,(02):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
Sun Hongping,Chen Guofang,Cao Wen,et al.Diabetes and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2014,(03):90.[doi:10.3760/cma.j.issn.1673-4157.2014.02.006]
[5]李秀娟,刘红梅.IgG4相关桥本甲状腺炎的研究进展[J].国际内分泌代谢杂志,2014,(04):257.[doi:10.3760/cma.j.issn.1673-4157.2014.04.012]
Li Xiujuan,Liu Hongmei..Recent progress of IgG4-related Hashimoto's thyroiditis[J].International Journal of Endocrinology and Metabolism,2014,(03):257.[doi:10.3760/cma.j.issn.1673-4157.2014.04.012]
[6]张倍宁 闫如意 周金莲 崔彦.甲状腺癌中miRNA的表达及作用[J].国际内分泌代谢杂志,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
Zhang Beining*,Yan Ruyi,Zhou Jinlian,et al.Expression and function of miRNA in thyroid carcinoma[J].International Journal of Endocrinology and Metabolism,2018,38(03):167.[doi:10.3760/cma.j.issn.1673-4157.2018.03.006]
[7]任秀利 柳艳萍 宋富军 王亭 倪明 张平平 刘明法.1990—2015年天津市滨海新区甲状腺癌
流行特征及长期发病趋势分析[J].国际内分泌代谢杂志,2020,40(02):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
Ren Xiuli,Liu Yanping,Song Fujun,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Binhai New Area of Tianjin from 1990 to 2015[J].International Journal of Endocrinology and Metabolism,2020,40(03):73.[doi:10.3760/cma.j.issn.1673-4157.2020.02.001]
[8]井超,王旭东.免疫治疗在甲状腺癌中的研究进展[J].国际内分泌代谢杂志,2021,41(05):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
Jing Chao,Wang Xudong..Research progress of immunotherapy in thyroid cancer[J].International Journal of Endocrinology and Metabolism,2021,41(03):459.[doi:10.3760/cma.j.cn121383-20210624-06069]
[9]赵静,李菲,晏蔚田,等.桥本甲状腺炎患者血浆外泌体miRNA表达谱研究[J].国际内分泌代谢杂志,2022,42(02):108.[doi:10.3760/cma.j.cn121383-20200911-09024]
Zhao Jing,Li Fei,Yan Weitian,et al.Differential expression profiles of plasma exosomal miRNA in Hashimoto's thyroiditis patients[J].International Journal of Endocrinology and Metabolism,2022,42(03):108.[doi:10.3760/cma.j.cn121383-20200911-09024]
[10]苏钢,洪娟,许继炜,等.桥本甲状腺炎患者外周血miR-454、miR-146a水平及意义探讨[J].国际内分泌代谢杂志,2022,42(03):174.[doi:10.3760/cma.j.cn121383-20210318-03048]
Su Gang,Hong Juan,Xu Jiwei,et al.Levels and significance of miR-454 and miR-146a in peripheral blood of patients with Hashimoto's thyroiditis[J].International Journal of Endocrinology and Metabolism,2022,42(03):174.[doi:10.3760/cma.j.cn121383-20210318-03048]
[11]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(03):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]